January 28-30, 2013 | HICC, Hyderabad

BioAsia 2013 – Conference Agenda

January 28, 2013

09:00-16:00 Hrs Workshops and BioPark Visit (Separate Registrations)

17:00-18:00 Hrs Inaugural Ceremony

18:00-19:00 Hrs Keynote Address

Trends in Global BioPharma R&D – Dr. Freda Lewis-Hall, Chief Medical Officer

– Worldwide, Pfizer, USA

19:00-20:30 Hrs Welcome Reception

January 29, 2013

09:30-10:15 Hrs Keynote Lecture – Dr. Bahija Jallal, Executive Vice President, Research &

Development, MedImmune, USA*

10:15-11:45 Hrs Biologics and Biosimilars: Succeeding in the market of the future

Current state of the Biologics and Biosimilars market, including mAbs.

Weighing Needs and Costs

Are the next Block buster’s coming from Biologics

Panelists:

Dr. Subir Basak, President (Global Discovery), Jubilant Lifesciences

Dr. Rajesh Ullanat, AVP & Head of Global Tech Development –

Biologics, Mylan Pharmaceuticals*

Mr. Melt Van Der Spuy, Chairman & Managing Director, Eli Lilly &

Company (India) Pvt. Ltd*

Dr. Himanshu Gadgill, Head – R&D, Intas Biopharmaceuticals Ltd.

Mr. Sachin Joshi, GM Bioprocess, GE Healthcare Pvt. Ltd.

Moderator - Mr. Jasmin Patel, Venture Partner, Aarin Capital

11:45-12:15 Hrs Speed Networking (Coffee / Tea Break)

12:15-13:45 Hrs Biomedical Research and Regulatory Environment

Fostering Biomedical Research in India

Recent Biosimilar guidelines of Government of India

US FDA's recent Guidance and it's impact

Lead Speaker:

Mr. Solomon Yimam, Asst. Country Director(Clinical Research), US FDA India

Panelists:

Mr. Satish Reddy, Managing Director & COO, Dr. Reddy’s

Laboratories, India*

Mr. Ravi Penmetsa, Managing Director, Gland Pharma

Dr AKS Bhujanga Rao, President (R&D and Technical), Natco Pharma*

Moderator – Mr. Vikas Dandekar, India Bureau Chief, Elsevier

Business Intelligence

13:45-15:00 Hrs Lunch and Visit to the exhibition

January 28-30, 2013 | HICC, Hyderabad

15:00-16:30 Hrs Role of Emerging Markets in global biologics arena: Would India

dominate 'Biosimilars'?

Challenges to Biologics and Biosimilars research especially in Asia

Is India ready to take a lead in Biosimilars /bio-better like it did in

small molecules generics /branded generics?

Lead Speaker:

Dr. Salomon Azoulay, SVP Medical & Development Emerging Markets, Pfizer

Panelists:

Mr. Baoping Wang, Head, Novo Nordisk, China

Dr. Alex Kudrin, Medical Assessor, Biological Licensing Division,

MHRA, UK

Mr. KV Subramaniam, President & CEO, Reliance Lifesciences

Moderator - Mr. Mike Ward, Editor-in-Chief, Scrip Intelligence, UK

16:30-18:00 Hrs Increasing Partnerships between Biologics Innovators and

Biosimilars manufacturers

Commonalities and differences between global cos and local firms

Bridging the innovation gap

Case studies

Lead Speaker:

Dr. Shyam Bishen, Head, Emerging Markets Strategy & Commercial

Development, Merck & Co.

Panelists:

Dr. Abhijit Barve, President – R&D, Biocon Ltd.*

Mr. C Bhaktavatsala Rao, Managing Director, Hospira Healthcare

Mr. C.L. Rathi, Managing Director, Advanced Enzymes

Moderator – Mr. Mahadevan Narayanamoni, Partner - Corporate

Finance, Healthcare & Life Sciences Leader, Grant Thornton

18:30-21:00 Hrs CEO Conclave (Only by Invitation)

January 30, 2013

09:30-10:15 Hrs Keynote Lecture – Dr. Sridaran Natesan, Vice President- External

Innovation (R&D), Science Strategy & Policy, Sanofi

10:15-11:45 Hrs Is Biologics and Biosimilars a not-to-miss opportunity? – Overall

perspective.

Panelists:

Dr. Ajit Shetty, VP Worldwide Operations, Johnson & Johnson &

Chairman, Board of Directors, Janssen Pharmaceutica, Belgium

Dr. Rustom Mody, Sr. Vice President – Head R&D, Biotechnology

Division - Lupin Ltd.

Dr. Charu Manaktala, Medical Director, Quintiles India

Mr. Anand Iyer, Head of Biotech Division, Strides Arcolabs Ltd.

Moderator - Mr. Aluri Srinivas Rao, Head – PE, Morgan Stanley PE

January 28-30, 2013 | HICC, Hyderabad

*Confirmations awaited

11:45-12:15 Hrs Speed Networking (Coffee / Tea Break)

12:15-13:45 Hrs Next Big Trends in Healthcare

Regenerative Medicine & Stem Cells

Chair:

Dr. Vishwa Mohan Katoch, Secretary to Government of India, Department of

Health Research, Ministry of Health & Family Welfare & Director General,

Indian Council of Medial Research*

Panelists:

Dr. D. Balasubramainam, Director Research, L. V. Prasad Eye

Institute

Shri Sreeshan Raghavan, Joint Secretary, Department of

Biotechnology, Govt. of India*

Dr. Mohan C. Vemuri, Director – Stem Cells, Life Technologies*

Dr. Dave Smith, Head, Cell Therapy, Lonza

Canadian FDA Representative*

13:45-15:00 Hrs Lunch & Visit to Exhibitions

15:00-16:30 Hrs Fostering Industry – Academia Linkages in Bio-Medical R&D

Missing Links and opportunities

Creating IP Ecosystem

Lead Speaker:

Dr. W. Selvamurthy, Distinguished Scientist & Chief Controller R&D, DRDO

Panelists:

Prof. Lam Kong Peng, Director, Bio-Processing Technology Institute,

A-Star, Singapore

Mr. Vinod Kuberkar, Managing Director, VTK Lifesciences Advisory

Services / Western Range Biopharmaceuticals Pvt. Ltd.

Dr. Taslimarif Saiyed, Director and COO, Centre for Cellular and

Molecular Platforms, NCBS-TIFR, Bangalore

16:30 – 17:00 Hrs Regulators’ Meet

17:00 Hrs Valedictory Ceremony & Close